An observational study demonstrating the adherence and ease of use of the injector device, RebiSmart®. (3rd May 2020)
- Record Type:
- Journal Article
- Title:
- An observational study demonstrating the adherence and ease of use of the injector device, RebiSmart®. (3rd May 2020)
- Main Title:
- An observational study demonstrating the adherence and ease of use of the injector device, RebiSmart®
- Authors:
- Vališ, Martin
Šarláková, Jana
Halúsková, Simona
Klímová, Blanka
Potužník, Pavel
Peterka, Marek
Kuča, Kamil
Štourač, Pavel
Mareš, Jan
Pavelek, Zbyšek - Abstract:
- ABSTRACT: Background: Adherence to Multiple Sclerosis (MS) treatment is considered one of the crucial factors for ensuring optimal clinical outcomes. Research has shown that the use of self-injector devices improves patient compliance with treatment. Therefore, the main purpose of this study is to evaluate the ease of use of RebiSmart® 2.0 in clinically isolated syndrome/relapsing-remitting MS patients during 12 months treatment period. Methods: A total number of 290 subjects entered into data collection; 249 (86%) of them completed the whole 12 months study period. The primary endpoints and the secondary endpoints were assessed by the User Study Questionnaire. Adherence data were retrieved from RebiSmart® 2.0 (Menu – Dose History) on the respective patient's visit. Outcome measures also included Expanded Disability Status Score, Kurtzke Functional Systems, and Modified Social Support Survey, Modified Social Support Survey-5. Results: This study demonstrated a very high proportion (>95%) of patients with a positive rating of the overall ease of use and the overall convenience of RebiSmart®. The proportion of patients with a positive rating of the ease of use by individual domains and the functions of RebiSmart® were also high (>80%). Conclusion: The findings demonstrate a very good perception of the usability of the device by patients overall and in its individual functions.
- Is Part Of:
- Expert opinion on drug delivery. Volume 17:Number 5(2020)
- Journal:
- Expert opinion on drug delivery
- Issue:
- Volume 17:Number 5(2020)
- Issue Display:
- Volume 17, Issue 5 (2020)
- Year:
- 2020
- Volume:
- 17
- Issue:
- 5
- Issue Sort Value:
- 2020-0017-0005-0000
- Page Start:
- 719
- Page End:
- 724
- Publication Date:
- 2020-05-03
- Subjects:
- Multiple Sclerosis -- patients -- adherence -- treatment -- use -- RebiSmart
Drug delivery devices -- Periodicals
Drug delivery systems -- Periodicals
615.605 - Journal URLs:
- http://informahealthcare.com/journal/edd ↗
http://www.ashley-pub.com/?cookieSet=1 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/17425247.2020.1742694 ↗
- Languages:
- English
- ISSNs:
- 1742-5247
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002941
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22948.xml